Approval · Notice of Compliance 10504 · 2009
AZARGA: Notice of Compliance 10504
Issued August 13, 2009
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 10504
- Date
- August 13, 2009
- Company
- Alcon Canada Inc.Mississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Therapeutic class
- Elevated intraocular pressure therapy
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| AZARGA | 02331624 | Marketed |
Medicinal ingredients
- BRINZOLAMIDE 1 PER
- TIMOLOL MALEATE 0.5 PER